Optimizing Antibodies for Antiviral Activity in vivo

Jun 2, 2021 11:10am ‐ Jun 2, 2021 11:35am

Speaker(s):


Single Cell Technologies Indicate Monocyte Expression Profiles Influence HIV Reservoir Size and Vaccine Efficacy

Jun 2, 2021 11:35am ‐ Jun 2, 2021 12:00pm

Speaker(s):


Short Talk: Broadly Neutralizing Antibody Recognition of HIV Envelope Epitopes Modulates Effector Function

Jun 2, 2021 12:00pm ‐ Jun 2, 2021 12:15pm

Speaker(s):


Short Talk: The High-affinity Immunoglobulin Receptor FcgRI Potentiates HIV-1 Neutralization via Antibodies against the gp41 N-heptad Repeat: Implications for Vaccine Development

Jun 2, 2021 12:15pm ‐ Jun 2, 2021 12:30pm

Speaker(s):


Short Talk: IgG Fc Sialylation is Regulated during the Germinal Center Reaction Following Immunization with Different Adjuvants

Jun 2, 2021 12:30pm ‐ Jun 2, 2021 12:45pm

Speaker(s):


Short Talk: Incorporating the Cluster A and V1V2 Targets into a Minimal Structural Unit of HIV-1 Envelope to Elicit Cross-Clade Response with Potent Fc-effector Functions

Jun 2, 2021 12:45pm ‐ Jun 2, 2021 1:00pm

Speaker(s):


[Joint Session] Live Poster Session Day 1

Jun 2, 2021 2:00pm ‐ Jun 2, 2021 3:30pm

[Joint Session] Meet the Editors Roundtable

Jun 2, 2021 3:30pm ‐ Jun 2, 2021 4:30pm

Speaker(s):


GC Regulation Learning from Mice and Men

Jun 3, 2021 8:00am ‐ Jun 3, 2021 8:25am

Speaker(s):


Optimizing Germinal Center Responses for Broadly Neutralizing Antibody Induction

Jun 3, 2021 8:00am ‐ Jun 3, 2021 10:25am

Co-Chair(s):